C19 Corp.
Biotechnology company · Hauppauge, New York, United States
C19 Corp. is a biotechnology company headquartered in Hauppauge, New York, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2020.
C19 at a glance
What does C19 do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $18 million sold (2020).
Frequently asked questions about C19
Where is C19 headquartered?
C19 Corp. is headquartered in Hauppauge, New York, United States.
What does C19 do?
C19 Corp. is a biotechnology company.
When was C19 founded?
The earliest incorporation on record for C19 Corp. is in 2020, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences